# Filing Detail

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0000950144-07-007248
Filing Date
2007-08-06
Accepted
2007-08-06 10:52:43
Documents
9

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | CUMBERLAND PHARMACEUTICALS INC. | g06286a5sv1za.htm | S-1/A | 2039073
2 | EX-4.1 SPECIMEN COMMON STOCK CERTIFICATE | g06286a5exv4w1.htm | EX-4.1 | 1407
3 | EX-10.1 MANUFACTURING AND SUPPLY AGREEMENT | g06286a5exv10w1.htm | EX-10.1 | 149581
4 | EX-23.1 CONSENT OF KPMG LLP | g06286a5exv23w1.htm | EX-23.1 | 2805
5 | EX-23.3 CONSENT OF MORGAN JOSEPH & CO INC. | g06286a5exv23w3.htm | EX-23.3 | 1627
6 | GRAPHIC | g06286a5g0628602.gif | GRAPHIC | 3768
7 | GRAPHIC | g06286a5g0628640.jpg | GRAPHIC | 1810318
8 | GRAPHIC | g06286a5g0628641.jpg | GRAPHIC | 489246
9 | GRAPHIC | g06286a5g0628610.gif | GRAPHIC | 337
| Complete submission text file | 0000950144-07-007248.txt |  | 5370413

Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: S-1/A | Act: 33 | File No.: 333-142535 | Film No.: 071026181
SIC: 2834 Pharmaceutical Preparations